EXPEDEON AG 
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 3.01M 3.25M 4.44M | Sales 2023 | 9M 9.71M 13.28M | Capitalization | 42.82M 46.2M 63.16M |
|---|---|---|---|---|---|
| Net income 2022 | -21M -22.66M -30.97M | Net income 2023 | 1M 1.08M 1.47M | EV / Sales 2022 | 11.1 x |
| Net cash position 2022 | 17.42M 18.79M 25.69M | Net cash position 2023 | 14.73M 15.89M 21.72M | EV / Sales 2023 | 3.12 x |
| P/E ratio 2022 |
-2.42
x | P/E ratio 2023 |
27.2
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 19.23% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 19-07-08 | |
Sebastian Paul
ADM | Chief Administrative Officer | - | 15-06-30 |
Robert Mayer
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 19-07-08 | |
Eva Katheder
BRD | Director/Board Member | - | 21-01-27 |
Jochen Hummel
BRD | Director/Board Member | 54 | 22-06-02 |
2Invest AG, formerly 4Basebio AG, is a Germany-based investment company. 2invest AG acquires, holds, manages and sells investments in corporations and partnership in the biotechnology, life science and information technologies (IT) sectors in Germany and abroad.
Sector
Investment Holding Companies
Calendar
2024-08-13
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +21.17% | 79.58B | |
| +67.35% | 18.68B | |
| +9.61% | 17.17B | |
| +10.85% | 14.54B | |
| +3.43% | 13.02B | |
| +8.26% | 12.08B | |
| +9.60% | 11.23B | |
| +42.47% | 10.55B | |
| -1.08% | 9.82B |
